Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Author/s
author: Ignace Vergote, Sandro Pignata, Bradley J. Monk, Jalid Sehouli, John Farley, Regina Berger, Elsa Kalbacher, Mansoor Raza Mirza, Esther Drill, Anneke Westermann, Ignacio Romero, Felix Hilpert, Peter Vuylsteke, Josep M. del Campo, David M. O'Malley, Cristina Churruca, Gopa Iyer, Kathleen N. Moore, Nicoletta Colombo, Robert L Coleman, Susana Banerjee, Rachel N. Grisham, Martin K Oehler, Carol Aghajanian, Amit M. Oza, Gunnar B. Kristensen, Andrew R Clamp, Christian Marth, Isabelle Ray-Coquard, David Cibula
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.